Recent outcome of grave's disease patients with papillary thyroid cancer

European Journal of Endocrinology

Volumn 157, Issue 3, 2007, Pages 325-329

  Yano, Yukiko ^a   Shibuya, Hiroshi ^a   Kitagawa, Wataru ^a   Nagahama, Mitsuji ^a   Sugino, Kiminori ^a   Ito, Kunihiko ^a   Ito, Koichi ^a  

^a ITO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; CASE CONTROL STUDY; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; ECHOGRAPHY; EUTHYROIDISM; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA; BLOOD; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 35348958352     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0136     Document Type: Article

References (13)

1. Belfiore A, Garofalo MB, Giuffrida D, Runello F, Filetti S, Fiumara A, Ippolito O & Vigneri R. Increased aggressiveness of thyroid cancer in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990 70 830-835.
2. Ozaki O, Ito K, Kobayashi K, Toshima K, Iwasaki H & Yashiro T. Thyroid carcinoma in Graves' disease. World Journal of Surgery 1990 14 437-440.
3. Mazzaferri EL. Thyroid cancer and Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990 70 826-829.
4. Pellegriti G, Belfiore A, Giuffrida D, Lupo L & Vigneri R. Outcome of differentiated thyroid cancer in Graves' patients. Journal of Clinical Endocrinology and Metabolism 1998 83 2805-2809.
5. Roger P, Taton M, Van Sande J & Dumont JE. Mitogenic effects of thyrotropin and adenosine 3′,5′-monophosphate in differentiated normal human thyroid cells in vitro. Journal of Clinical Endocrinology and Metabolism 1988 66 1158-1165.
6. Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R & Ingbar SH. The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer. New England Journal of Medicine 1988 318 753-759.
7. Katz SB, Garcia AJ & Niepomniszcze H. Development of Graves' disease nine years after total thyroidectomy due to follicular carcinoma of the thyroid. Thyroid 1997 7 909-911.
8. Cantalamessa L, Baldini M, Orsatti A, Meroni L, Amodei V & Castagnone D. Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Archives of Internal Medicine 1999 159 1705-1708.
9. Kikuchi S, Noguchi S, Yamashita H, Uchino S & Kawamoto H. Prognosis of small thyroid cancer in patients with Graves' disease. British Journal of Surgery 2006 93 434-439.
10. Hales IB, McElduff A, Crummer P, Clifton-Bligh P, Delbridge L, Hoschl R, Poole A, Reeve TS, Wilmshurst E & Wiseman J. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. Journal of Clinical Endocrinology and Metabolism 1992 75 886-889.
11. Belfiore A, Russo D, Vigneri R & Filetti S. Graves' disease, thyroid nodules and thyroid cancer. Clinical Endocrinology 2001 55 711-718.
12. Sugino K, Ito K, Ozaki O, Mimura T, Iwasaki H & Wada N. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease? World Journal of Surgery 1999 23 727-731.
13. Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H & Ito K. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. Journal of Endocrinological Investigation 1997 20 452-461.